drugset / Trial / NCT00272441

Summary

To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.

Timeline

Start
2001-01
Primary completion
—
Completion
2004-09

Outcome

Missed primary endpoint

paper During the observation year, no significant differences were seen between the two groups in the proportion of episode-free days PMID 16687711 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 88 ug Inhaled

Indications